Potency of clinical group B streptococcal conjugate vaccines (Q32067267)

6 July 2017

title

Potency of clinical group B streptococcal conjugate vaccines (English)

1 reference

6 July 2017

Paoletti LC

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

6 July 2017

1 reference

inferred from page(s)

published in

Vaccine

1 reference

6 July 2017

1 reference

6 July 2017

issue

15-16

1 reference

6 July 2017

page(s)

2118-2126

1 reference

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

Neonatal mouse model of group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

Therapeutic potential of human antisera to group B streptococcal glycoconjugate vaccines in neonatal mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900437-0

7 January 2021

10.1016/S0264-410X(00)00437-0

Identifiers

DOI

1 reference

6 July 2017

1 reference